Kähler, K. C., Gutzmer, R., Meier, F., Zimmer, L., Heppt, M. V., Gesierich, A., . . . Ugurel, S. (2021). Early exanthema upon vemurafenib plus cobimetinib is associated with a favorable treatment outcome in metastatic melanoma: A retrospective multicenter DeCOG study. Frontiers in oncology, 11, . https://doi.org/10.3389/fonc.2021.672172
Chicago Style (17th ed.) CitationKähler, Katharina C., et al. "Early Exanthema upon Vemurafenib Plus Cobimetinib Is Associated with a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study." Frontiers in Oncology 11 (2021). https://doi.org/10.3389/fonc.2021.672172.
MLA (9th ed.) CitationKähler, Katharina C., et al. "Early Exanthema upon Vemurafenib Plus Cobimetinib Is Associated with a Favorable Treatment Outcome in Metastatic Melanoma: A Retrospective Multicenter DeCOG Study." Frontiers in Oncology, vol. 11, 2021, https://doi.org/10.3389/fonc.2021.672172.